In 2023, Natco Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Natco Pharma generated a total of 2,306 metric tonnes of waste.
Of this amount, 119.26% of Natco Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 28.57% was disposed of through landfilling, incineration, or combustion.
In 2023, Natco Pharma reported a total waste generation of 2,306 metric tonnes, of which 119.26% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Natco Pharma has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Since 2023, Natco Pharma's total waste generation has increased by 14.38%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.
Over the same period, Natco Pharma's waste recovery rate increased by 29.61%.
In 2023, Natco Pharma generated a total of 2,306 metric tonnes of waste.
Of this amount, 97.49% of Natco Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 2.51% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2023, Natco Pharma's total waste generation has increased by 14.38%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.
Since 2023, Natco Pharma's hazardous waste generation has increased by 0.54%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..
Overall, Natco Pharma's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.